Talk:Janet Wolfe
From Wikipedia, the free encyclopedia
 |
This article was nominated for deletion on 25 April 2008. The result of the discussion was No consensus to delete. |
Dear Wiki - I would like to defend the deletion of the Janet Wolfe Page. I would like to provide more details about Janet's importance in the biopharmaceutical industry. Her success as a woman entrepreneur in this industry is rare and is setting a precedent for future female leadership.
Fresh out of a post doctoral fellowship at the National Institutes of Health, Janet felt called to academia, serving as an assistant professor of pharmaceutical sciences at the University of Tennessee. While teaching, she began designing research programs, an activity which required raising funds, hiring people and forming her own operations team. As she combined her love for science with her passion for free enterprise, Janet laid the foundation for her future career as an entrepreneur.
When her family moved to the Boston area in 1999, Janet could have gone into the biopharmaceutical industry, but she was used to running her own show. She recognized the abundance of emerging biotech and pharmaceutical companies in the Boston area and foresaw high demand for experienced pharmaceutical chemists. In 1999, she rented a 2,000 square foot facility in Newton, MA and formed WLI. Consulting and conducting contract research part-time to accommodate her three children’s school schedules, Janet re-invested most of the revenue back into her business. In an effort to recruit clients and promote the company, she personally sent out mass mailings to all of her associates and other professionals in the field. In 2001, she narrowed her focus to laboratory-based contract research and secured small, early stage drug development projects. Each year, she would reinvest the revenue and continue to grow the company by anticipating demand and evolving with the ever-changing marketplace.
The pharmaceutical development industry demands innovation and keen business acumen. Janet has stayed ahead of the competition by customizing preclinical discovery and development services for her clients. Many customers have advanced their programs through various stages in clinical trials and successfully licensed products for commercial use. Growing client referrals have augmented continued growth since the company’s inception.
Janet’s commitment to excellence and innovative thinking has enabled her to build a company that boasts seven years of profitability and multi-million dollar revenue. From the initial efforts of just one person, WLI currently staffs thirty unique, scientifically diverse and talented employees. The company has recently moved to a 21,000 square foot facility with state-of-the-art laboratories in Watertown. This move is a product of a careful business strategy and is a milestone in the continued growth of WLI.
However, Janet never stops looking to the future and preparing for the next big step. She recently accepted a position to serve on a National Institutes of Health review panel for stability contract proposals.
- Unfortunately her wonderful personal qualities aren't really encyclopedic. However opening such a large facility and being president of it probably is. The article needs to focus on that and put in a few sources and it will probably be just fine. Beach drifter (talk) 20:10, 26 March 2008 (UTC)
